Stock Forecast

  Field Trip Health Ltd. ( FTRP) Stock. Should you Buy or Sell?    $ 0.84

0.01 (0.80 %)



Field Trip Health Ltd. Analysis

Updated on 10-09-2022
Symbol FTRP
Price $0.84
Beta 0.000
Volume Avg. $61.09 thousand
Market Cap $9.82 M
52 Week Range $0.8141 - $32.05


Field Trip Health Ltd. opened the day at $0.84 which is +'0.80 % on yesterday's close. Field Trip Health Ltd. has a 52 week high of $32.05 and 52 week low of $0.8141, which is a difference of $31.2359. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $9.82 M and total net profit is $4860129 which means the company is trading at 2.02 times profit to market capitalization. Theoretically, if you were to buy Field Trip Health Ltd. for $9.82 M, it would take 15 years to get your money back. Field Trip Health Ltd. are in the Medical Care Facilities space which will have a sweet spot and industry standard for net profit multiples.



Price Chart


1 D | All


Financials




Field Trip Health Ltd. Stock Forecast - Is Field Trip Health Ltd. a Buy or Sell?


DCF ScoreStrong Buy
ROE ScoreSell
ROA ScoreSell
DE ScoreBuy
PE ScoreSell
PB ScoreStrong Buy
Overall RecommendationBuy

Growth and Value


PE Ratio -0.222
Dividend Yiel 0.000
Net Profit Margin -13.929


Valuing Field Trip Health Ltd.


Price Book Value Ratio 0.231 Price To Book Ratio 0.231
Price To Sales Ratio 3.091 Price Earnings Ratio -0.222


How liquid is Field Trip Health Ltd.


Current Ratio 2.534
Quick Ratio 1.387


Debt


Debt Ratio 0.394 Debt Equity Ratio 0.651
Long Term Debt To Capitalization 0.000 Total Debt To Capitalization 0.000



Latest news about Field Trip Health Ltd.


Field Trip Health Ltd. (FTRP) CEO Joseph Del Moral on Q1 2023 Results - Earnings Call Transcript

Field Trip Health Ltd. (NASDAQ:FTRP ) Q1 2023 Earnings Conference Call August 16, 2022 8:30 AM ET Company Participants Kathleen Heaney - KCSA Strategic Communications Ronan Levy - Chairman and Chief Executive Officer of Field Trip Health & Wellness Joseph Del Moral - Chairman and Chief Executive Officer Donna Wong - Chief Financial Officer Nathan Bryson - Chief Scientific Officer Conference Call Participants Andrew Partheniou - Stifel Nicolaus Patrick Trucchio - H.C.

Date : 16/08/2022

Field Trip Health Ltd. (FTRP) CEO Joseph Del Moral on Q4 2022 Results - Earnings Call Transcript

Field Trip Health Ltd. (NASDAQ:FTRP ) Q4 2022 Earnings Conference Call June 30, 2022 8:30 AM ET Company Participants Kathleen Heaney - Investor Relations Joseph Del Moral - Co-Founder and Chief Executive Officer Ronan Levy - Co-Founder and Executive Chairman Donna Wong - Chief Financial Officer Paula Hewitt - Vice President and General Counsel Nathan Bryson – Chief Scientific Officer Conference Call Participants Andrew Partheniou - Stifel Patrick Trucchio - H.C.

Date : 30/06/2022

Earnings Previews: Constellation Brands, Field Trip Health, NovaGold, Walgreens

The three major U.S. equity indexes closed lower Monday, with the Nasdaq dipping by 0.72%, the S&P 500 sliding 0.3% and the Dow Jones industrials closing down 0.2%.

Date : 28/06/2022

Field Trip Health Ltd. to Present at the H.C.

TORONTO, June 23, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that Field Trip's Co-founder and Executive Chairman, Ronan Levy, and Chief Scientific Officer, Dr. Nathan Bryson, will participate in a live fireside chat at the H.C. Wainwright 1st Annual Mental Healthcare Conference taking place June 27, 2022.

Date : 23/06/2022

Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2022 Results Conference Call for Thursday, June 30, 2022 at 8:30 AM ET

- Discloses Receipt Of Nasdaq Non-Compliance With Minimum Price Notice - Discloses Receipt Of Nasdaq Non-Compliance With Minimum Price Notice

Date : 22/06/2022





About Field Trip Health Ltd.


CEO :
Sector : Healthcare
Industry : Medical Care Facilities

Website : https://www.fieldtriphealth.com

Exchange : NASDAQ Global Select

Description :

Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.


My Newsletter

Sign Up For Updates & Newsletters